TFC Financial Management’s Quest Diagnostics DGX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$5.68K Hold
29
﹤0.01% 443
2025
Q4
$5.03K Hold
29
﹤0.01% 448
2025
Q3
$5.53K Sell
29
-3
-9% -$532 ﹤0.01% 444
2025
Q2
$5.75K Buy
32
+3
+10% +$521 ﹤0.01% 410
2025
Q1
$4.91K Hold
29
﹤0.01% 407
2024
Q4
$4.38K Hold
29
﹤0.01% 428
2024
Q3
$4.5K Hold
29
﹤0.01% 429
2024
Q2
$3.97K Buy
29
+4
+16% +$548 ﹤0.01% 410
2024
Q1
$3.33K Sell
25
-3
-11% -$389 ﹤0.01% 418
2023
Q4
$3.86K Sell
28
-2
-7% -$263 ﹤0.01% 401
2023
Q3
$3.66K Buy
30
+5
+20% +$666 ﹤0.01% 410
2023
Q2
$3.51K Sell
25
-2
-7% -$276 ﹤0.01% 393
2023
Q1
$3.82K Buy
27
+2
+8% +$286 ﹤0.01% 413
2022
Q4
$3.91K Hold
25
﹤0.01% 349
2022
Q3
$3K Hold
25
﹤0.01% 370
2022
Q2
$3K Hold
25
﹤0.01% 363
2022
Q1
$3K Hold
25
﹤0.01% 373
2021
Q4
$4K Hold
25
﹤0.01% 405
2021
Q3
$4K Hold
25
﹤0.01% 397
2021
Q2
$3K Hold
25
﹤0.01% 397
2021
Q1
$3K Hold
25
﹤0.01% 392
2020
Q4
$3K Hold
25
﹤0.01% 389
2020
Q3
$3K Buy
+25
New +$2.95K ﹤0.01% 367

Other funds holding DGX

TFC Financial Management's DGX Position: Q1 2026 in Review

TFC Financial Management held its Quest Diagnostics (DGX) position steady in Q1 2026 at 29 shares worth $5.68K. The position accounts for ﹤0.01% of the portfolio, ranked #443.

TFC Financial Management first reported a position in DGX in Q3 2020 and has held it in 23 quarters since. The position peaked at $5.75K in Q2 2025. 1,063 funds tracked by Wall St. Rank hold DGX as of Q1 2026.

  • TFC Financial Management held 29 shares of Quest Diagnostics worth $5.68K as of Q1 2026.
  • TFC Financial Management left its Quest Diagnostics share count unchanged in Q1 2026.
  • Quest Diagnostics made up ﹤0.01% of TFC Financial Management's portfolio in Q1 2026, its #443 holding.
  • TFC Financial Management first reported a position in Quest Diagnostics in Q3 2020 and has held it in 23 quarters since.
  • TFC Financial Management's Quest Diagnostics position peaked at $5.75K in Q2 2025.
  • 1,063 funds tracked by Wall St. Rank held Quest Diagnostics as of Q1 2026.

Based on TFC Financial Management's 13F filing for Q1 2026, filed 23 Apr 2026.